RNATICS
PrivateLast Round
Grant
Feb 20, 2026
Total Funding Raised
$11.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RNATICS operates in Healthcare & Life Sciences and is based in Germany. Its latest recorded funding round was a Grant round in February 2026.
RNATICS is a drug discovery company that develops RNA-based therapeutic methods intended for the treatment of severe diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RNATICS Comparables
Compare RNATICS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SpliSense | 79% | |
| Novartis | 69% | |
| Avalyn Pharma | 69% |
For institutional investors. Book with your work email.
RNATICS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2026 | ||||
| Accelerator | Jun 26, 2024 | ||||
| Grant | Jan 13, 2022 | ||||
| Spinoff | Jan 1, 2021 |
For institutional investors. Book with your work email.
RNATICS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Technical University of Munich | Spinoff |
| Munich Accelerator Life Sciences & Medicine | Accelerator |
| BioM AG Munich BioTech Development | Accelerator |
| Federal Ministry of Research, Technology and Space | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 67% MoM, reaching 1.9K.
- May 15, 2026
Monthly visitors increased 276% MoM.
For institutional investors. Book with your work email.
RNATICS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RNATICS's valuation, stock price, and market status.
Is RNATICS a public or private company?
RNATICS is a private company.
What is the current stock price of RNATICS?
RNATICS is a private company, so its shares have no public market price. Caplight tracks RNATICS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RNATICS worth (valuation)?
Valuation information for RNATICS is not publicly available.
Can I buy RNATICS stock?
RNATICS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RNATICS's last funding round?
RNATICS's most recent funding round was Grant on February 20, 2026.
Who are the main investors in RNATICS?
Key investors in RNATICS include Technical University of Munich, Federal Ministry of Research, Technology and Space.
Will RNATICS IPO soon?
No public IPO plans have been announced for RNATICS.
How can I track RNATICS secondary market activity?
Caplight tracks bids, offers, and trades in RNATICS's shares on secondary markets.